T. Al Janaby, S. Khelwatty, I. Bagwan, N. Abbassi-Ghadi, and H. Modjtahedi, “Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma”, World J Oncol, Apr. 2025, doi: 10.14740/wjon2552.